Our pilot study of the genomic profile of patients with CRC showed that gene and SNVs in at least 90% of all samples consisted of a total of 43 genes comprising 286 variants, with most variants being STK11, SMAD4, EGFR, ERBB4. This evidence concerns the gene SMAD4 and colorectal carcinoma.